RE:ADC Plus immunotherapy a proven conceptIf those AACR poster results are very strong, it shoudl get some attention. I completely agree that there are 3 possibilities for them to push their science in combos and as a pre/post anti=metastatic. It would be a real wildcard if those numbers are good and they can convince someone to come in on a small trial. Cost wouldn't be high for that versus other types of trials. Given the market sizes, it would definitely be worth the spin of the wheel for someone. It's worthwhile to explore in the call and see the AACR numbers. It seems the ADC/PDC combo with approved therapies is growing rapidly. They need to jump on that.